Abstract:Background: The use of non-invasive ventilation is controversial in immunocompromised patients with acute respiratory failure, whereas the use of high-flow nasal cannula oxygen therapy is growing as an alternative to standard oxygen. We aimed to compare outcomes of immunocompromised patients with acute respiratory failure treated with standard oxygen with those treated with high-flow nasal cannula oxygen alone or high-flow nasal cannula oxygen associated with non-invasive ventilation. Methods: We did a post-hoc subgroup analysis in a subset of immunocompromised patients with non-hypercapnic acute respiratory failure from a multicentre, randomised, controlled trial. In the trial, patients from 23 intensive care units in France and Belgium were randomly assigned (1:1:1) to receive either standard oxygen, high-flow nasal cannula alone, or non-invasive ventilation interspaced with high-flow nasal cannula between non-invasive ventilation sessions (non-invasive ventilation group). Patients with profound neutropenia, acute-on-chronic respiratory failure, cardiogenic pulmonary oedema, shock, or altered consciousness were excluded. The primary outcome was the proportion of patients who required endotracheal intubation within 28 days after randomisation. Findings: Of the 82 immunocompromised patients, 30 were treated with standard oxygen, 26 with high-flow nasal cannula alone, and 26 with non-invasive ventilation plus interspaced high-flow nasal cannula. 8 (31%) of 26 patients treated with high-flow nasal cannula alone, 13 (43%) of 30 patients treated with standard oxygen, and 17 (65%) of 26 patients treated with non-invasive ventilation required intubation at 28 days (p=0·04). Odds ratios (ORs) for intubation were higher in patients treated with non-invasive ventilation than in those treated with high-flow nasal cannula: OR 4·25 (95% CI 1·33-13·56). ORs were not significantly different between patients treated with high-flow nasal cannula alone and standard oxygen: OR 1·72 (0·57-5·18). After multivariable logistic regression, the two factors independently associated with endotracheal intubation and mortality were age and use of non-invasive ventilation as first-line therapy. Interpretation: Non-invasive ventilation might be associated with an increased risk of intubation and mortality and should be used cautiously in immunocompromised patients with acute hypoxaemic respiratory failure. Funding: French Ministry of Health, the French societies of intensive care (Société de Réanimation de Langue Française, SRLF) and pneumology (Société de Pneumologie de Langue Française, SPLF), La Mutuelle de Poitiers, AADAIRC (Association pour l'Assistance à Domicile Aux Insuffisants Respiratoires Chroniques), and Fisher&Paykel Healthcare.

Use of Noninvasive Ventilation in Immunocompromised Patients with Acute Respiratory Failure: A Systematic Review and Meta-Analysis

Incidence of noninvasive ventilation failure and mortality in patients with acute respiratory distress syndrome: a systematic review and proportion meta-analysis

High-flow oxygen therapy in immunocompromised patients with acute respiratory failure: A review and meta-analysis

Noninvasive Ventilation on Mortality of Acute Respiratory Distress Syndrome.

Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update

The efficacy of high-flow nasal cannula (HFNC) versus non-invasive ventilation (NIV) in patients at high risk of extubation failure: a systematic review and meta-analysis

Pathophysiological Basis of Acute Respiratory Failure on Non-Invasive Mechanical Ventilation

[Non-invasive ventilation in acute respiratory failure of oncology-hematology patients: What are its current benefits and limitations?]

Noninvasive Ventilation in Critically Ill Patients With Severe Acute Respiratory Infections

Defining Failure of Noninvasive Ventilation for Acute Respiratory Distress Syndrome: Have We Succeeded?

Risk Factors of Non-Invasive Ventilation Failure in Hematopoietic Stem-Cell Transplantation Patients with Acute Respiratory Distress Syndrome

Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders

Risk factors for non-invasive ventilation failure in influenza infection with acute respiratory failure in emergency department

Non-invasive ventilation in acute respiratory failure

Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS

Noninvasive Ventilation for Moderate to Severe Acute Respiratory Distress Syndrome Due to COVID-19

Use of nasal high flow oxygen during acute respiratory failure

Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial

High-frequency Oscillatory Ventilation in Patients with Acute Respiratory Distress Syndrome: a Meta-Analysis

Early non-invasive ventilation treatment for respiratory failure due to severe community-acquired pneumonia

Noninvasive mechanical ventilation in patients with acute respiratory failure